aTyr Pharma Inc (NASDAQ:LIFE)

Delayed Data
As of Jun 08
 -0.03 / -1.30%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 19.00, with a high estimate of 35.00 and a low estimate of 9.00. The median estimate represents a +737.00% increase from the last price of 2.27.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.66%
Growthannually 35.00%


Growthquarterly --
Growthannually -26.82%
Key to the earnings and sales forecast charts.